Trigger tools to identify adverse drug events in hospitalised children: A systematic review

Rama Arab1, Catherine Cornu2, Roubi Kilo3

  • 1Laboratoire de biométrie et biologie évolutive, CNRS, UMR 5558, université de Claude-Bernard Lyon 1, 8, rue Guillaume-Paradin, Bât B 69008, 69008 Lyon, France.

Therapie
|February 22, 2022
PubMed

Insights

This study identified 271 triggers for detecting adverse drug events (ADEs) in children. While some triggers show high positive predictive value (PPV), further research is needed to optimize real-time ADE detection systems for pediatric patients.

Area of Science:

  • Pediatric pharmacology
  • Patient safety
  • Health informatics

Background:

  • Adverse drug events (ADEs) are a significant concern in pediatric healthcare.
  • Effective detection methods are crucial for improving patient safety in children.
  • Current trigger tools for ADE detection in pediatric populations require thorough evaluation.

Purpose of the Study:

  • To comprehensively identify and evaluate trigger tools for detecting ADEs in hospitalized children.
  • To assess the performance of these triggers using positive predictive value (PPV).
  • To explore the utility of triggers in real-time ADE detection systems for pediatric care.

Main Methods:

  • A systematic literature search of PubMed was conducted up to December 2021.
  • Studies utilizing triggers for ADE identification in pediatric inpatients were included.
  • Triggers related exclusively to care procedures were excluded; only ADE-specific triggers were analyzed.

Main Results:

  • A total of 271 unique triggers were identified across 30 studies, with 179 linked to drug-induced harms.
  • Nineteen triggers (11%) demonstrated a mean PPV between 50% and 100%, including five with 100% PPV.
  • Identified triggers varied in their applicability for ADE prevention, verification, and reporting.

Conclusions:

  • Individual trigger performance requires further rigorous investigation.
  • Computerized triggers and real-time detection systems for ADEs in children represent a critical but emerging area.
  • The frequent off-label use of medications in children underscores the need for enhanced ADE detection strategies.
Abstract

Related Concept Videos

Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.0K
Drug Regulation01:25

Drug Regulation

Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
2.0K
Hazard Ratio01:12

Hazard Ratio

The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
278
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.5K
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
70
Therapeutic Index01:13

Therapeutic Index

The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
5.4K